rs137852525
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_001278116.2(L1CAM):c.2254G>A(p.Val752Met) variant causes a missense change. The variant allele was found at a frequency of 0.00000182 in 1,097,920 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000018 ( 0 hom. 0 hem. )
Consequence
L1CAM
NM_001278116.2 missense
NM_001278116.2 missense
Scores
10
6
1
Clinical Significance
Conservation
PhyloP100: 6.16
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a domain Fibronectin type-III 2 (size 93) in uniprot entity L1CAM_HUMAN there are 5 pathogenic changes around while only 1 benign (83%) in NM_001278116.2
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.989
PP5
Variant X-153866826-C-T is Pathogenic according to our data. Variant chrX-153866826-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 9998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L1CAM | NM_001278116.2 | c.2254G>A | p.Val752Met | missense_variant | 19/29 | ENST00000370060.7 | NP_001265045.1 | |
L1CAM | NM_000425.5 | c.2254G>A | p.Val752Met | missense_variant | 18/28 | NP_000416.1 | ||
L1CAM | NM_024003.3 | c.2254G>A | p.Val752Met | missense_variant | 18/27 | NP_076493.1 | ||
L1CAM | NM_001143963.2 | c.2239G>A | p.Val747Met | missense_variant | 17/26 | NP_001137435.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L1CAM | ENST00000370060.7 | c.2254G>A | p.Val752Met | missense_variant | 19/29 | 5 | NM_001278116.2 | ENSP00000359077.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD3 exomes AF: 0.00000549 AC: 1AN: 182191Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66961
GnomAD3 exomes
AF:
AC:
1
AN:
182191
Hom.:
AF XY:
AC XY:
0
AN XY:
66961
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1097920Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 363330
GnomAD4 exome
AF:
AC:
2
AN:
1097920
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
363330
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
X-linked hydrocephalus syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Oct 08, 2024 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with partial agenesis of corpus callosum (MIM#304100), congenital hydrocephalus (MIM#307000), and MASA syndrome (MIM#303350). (I) 0109 - This gene is associated with X-linked recessive disease. (I) 0115 - Variants in this gene are known to have variable expressivity. Both interfamilial and intrafamilial variability have been reported (PMID: 7562969,16650080). (I) 0200 - Variant is predicted to result in a missense amino acid change from valine to methionine. (I) 0253 - This variant is hemizygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 1 heterozygote, 0 homozygotes, 0 hemizygotes). (SP) 0502 - Missense variant with conflicting in silico predictions and high conservation. (I) 0600 - Variant is located in the annotated fibronectin type III domain (DECIPHER; PMID: 11772994). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in multiple hemizygous male individuals with hydrocephalus (PMID: 11857550, 9268105, 17328266, 35088901). Additionally, it has been reported as pathogenic by a clinical laboratory (ClinVar). (SP) 1002 - This variant has moderate functional evidence supporting abnormal protein function. It has been shown to reduce homophilic L1 binding and TAX-1 binding, as well as having reduced cell surface expression, relative to wild-type protein (PMID: 11772994). (SP) 1101 - Very strong and specific phenotype match for this individual. (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 15, 2002 | - - |
Spastic paraplegia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 24, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects L1CAM function (PMID: 11772994). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on L1CAM protein function. ClinVar contains an entry for this variant (Variation ID: 9998). This missense change has been observed in individual(s) with L1CAM-related conditions (PMID: 9268105, 11857550, 17328266, 19953645, 23820807). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 752 of the L1CAM protein (p.Val752Met). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2024 | Published functional studies demonstrate a damaging effect including reduced homophilic binding and reduced binding to TAX-1 (PMID: 11772994); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 35088901, 10767310, 19846429, 36307859, 33768880, 37453721, Ahmed2023[casereport], 25641508, 9268105, 11857550, 11772994, 17328266) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
.;D;.;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;M;.;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
1.0
.;D;.;D
Vest4
MutPred
0.91
.;Gain of catalytic residue at V748 (P = 0.0473);.;Gain of catalytic residue at V748 (P = 0.0473);
MVP
MPC
1.5
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at